Literature DB >> 6401762

Effects of disodium EDTA and calcium infusion on prolactin and thyrotropin responses to thyrotropin-releasing hormone in healthy man.

R Dudczak, W K Waldhäusl, P Bratusch-Marrain.   

Abstract

To determine the impact of induced hypo- and hypercalcemia on TRH (400 micrograms)-stimulated TSH and PRL release, healthy subjects (n = 11) were infused with 5% glucose in water (n = 11), disodium EDTA (n = 11), or calcium gluconate (n = 7). TRH was given as an iv bolus 60 min (5% glucose and EDTA) and 120 min (calcium) after initiation of the respective infusion. Basal plasma concentrations of TSH remained unchanged during induced hypo- and hypercalcemia, whereas those of PRL fell during the latter (P less than 0.05). The mean sum of increments (0-90 min) in PRL and TSH was considerably greater during hypocalcemia than during hypercalcemia (PRL, P less than 0.002; TSH, P less than 0.005). The increments in the plasma hormone concentration above basal after iv TRH were increased compared to those in normocalcemia (PRL, 98.4 +/- 37.9 ng/ml; TSH, 38.9 +/- 11.8 microU/ml) during hypocalcemia [PRL, 128 +/- 47.8 ng/ml (P less than 0.002); TSH, 46.7 +/- 12.8 microU/ml; (P less than 0.005)], but were impaired during hypercalcemia [PRL, 70.1 +/- 27 ng/ml (P less than 0.002); TSH, 28.9 +/- 8.5 microU/ml (P less than 0.025)]. The mean sum of increments in PRL was related to concentrations of both serum calcium (r = -0.59; P less than 0.01) and PTH (r = 0.51; P less than 0.05). A relation was also seen between the incremental responses of TSH and serum calcium (r = -0.52; P less than 0.05), PTH (r = 0.55; P less than 0.01), and phosphorus (r = -0.55; P less than 0.01). We conclude that in healthy man, TRH-mediated release of both PRL and TSH are inversely related to serum calcium concentrations in such a manner that hormone secretion is enhanced by acute hypocalcemia, but blunted by hypercalcemia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401762     DOI: 10.1210/jcem-56-3-603

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

2.  Hyperthyroxinemia after surgery for primary hyperparathyroidism.

Authors:  A Bergenfelz; B Ahrén
Journal:  Langenbecks Arch Chir       Date:  1994

3.  Acute effect of cimetidine and pirenzepine on plasma parathyroid hormone and calcitonin in haemodialyzed patients.

Authors:  J Zazgornik; R Dudczak; M Fuhrmann; L Marosi; E Minar; P Balcke
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Actions of calcium ions and a calcium-influx blocker on basal and TRH- and GnRH-stimulated hormone release in patients with pituitary adenomas.

Authors:  M Davis; B Nassberg; J L Borges; A Iranmanesh; G Lizzaralde; R J Santen; C Drake; A D Rogol; D L Kaiser; M O Thorner
Journal:  J Endocrinol Invest       Date:  1987-10       Impact factor: 4.256

5.  Effect of combination therapy with cimetidine and pirenzepine on plasma parathyroid hormone and calcitonin levels in hemodialyzed patients.

Authors:  E Minar; J Zazgornik; R Dudczak; L Marosi
Journal:  Klin Wochenschr       Date:  1984-06-01

6.  Effect of chronic endogenous hypercalcemia on prolactin and thyrotropin responsiveness in man.

Authors:  S Röjdmark; E Edström; M Nordlund
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

7.  Effect of 1,25-dihydroxyvitamin D3 and nifedipine on prolactin release in normal man.

Authors:  D Verbeelen; L Vanhaelst; M Fuss; A C Van Steirteghem
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.